Powers Advisory Group’s Medtronic MDT Stock Holding History

Powers Advisory Group’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$292K	Sell	3,374 -145	-4%	-$13.9K	0.1%	105
2025 Q4	$338K	Hold	3,519	–	–	0.13%	91
2025 Q3	$335K	Sell	3,519 -322	-8%	-$29.6K	0.13%	89
2025 Q2	$335K	Sell	3,841 -50	-1%	-$4.24K	0.15%	87
2025 Q1	$350K	Buy	3,891 +289	+8%	+$25.9K	0.17%	80
2024 Q4	$288K	Hold	3,602	–	–	0.14%	83
2024 Q3	$324K	Sell	3,602 -25	-0.7%	-$2.1K	0.16%	79
2024 Q2	$285K	Hold	3,627	–	–	0.16%	84
2024 Q1	$316K	Buy	3,627 +821	+29%	+$70.1K	0.18%	77
2023 Q4	$231K	Buy	+2,806	New	+$214K	0.14%	87

Other funds holding MDT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Powers Advisory Group's MDT Position: Q1 2026 in Review

Powers Advisory Group reduced its Medtronic (MDT) stake by 4.1% in Q1 2026, selling an estimated $13.9K and leaving 3,374 shares worth $292K. The position accounts for 0.1% of the portfolio, ranked #105.

Powers Advisory Group first reported a position in MDT in Q4 2023 and has held it in 10 quarters since. The position peaked at $350K in Q1 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

Powers Advisory Group held 3,374 shares of Medtronic worth $292K as of Q1 2026.
Powers Advisory Group sold 145 Medtronic shares in Q1 2026, an estimated $13.9K.
Medtronic made up 0.1% of Powers Advisory Group's portfolio in Q1 2026, its #105 holding.
Powers Advisory Group first reported a position in Medtronic in Q4 2023 and has held it in 10 quarters since.
Powers Advisory Group's Medtronic position peaked at $350K in Q1 2025.
2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Powers Advisory Group's 13F filing for Q1 2026, filed 21 Apr 2026.